Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities

ABSTRACT: Glycolytic shift during West Nile virus infection provides new therapeutic opportunities

PROVIDER: PRJNA975479 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24705800_1.fastq.gz	Fastqsanger.gz
	SRR24705800_2.fastq.gz	Fastqsanger.gz
	SRR24709800_1.fastq.gz	Fastqsanger.gz
	SRR24709800_2.fastq.gz	Fastqsanger.gz
	SRR24705801_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 174

Similar Datasets

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [Brain]

Project description:Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [Brain]

| PRJNA975481 | ENA

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [Cerebellum]

Project description:Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [Cerebellum]

| PRJNA975484 | ENA

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [2DG and DGA compounds]

Project description:Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [2DG and DGA compounds]

| PRJNA975482 | ENA

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-09-27 | GSE233218 | GEO

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [Cerebellum]

Project description:To investigate the in vivo metabolic changes during WNV infection in a mouse model, we infected mice with WNV NY99 to compare to uninfected (mock) mice. We also use two compounds targeting energetic metabolism to analysed their effects on WNV infection We then performed gene expression profiling analysis using data obtained from RNA-seq from infected vs uninfected mice and treated mice.

2023-09-27 | GSE233217 | GEO

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [Brain]

2023-09-27 | GSE233216 | GEO

Glycolytic shift during West Nile virus infection provides new therapeutic opportunities [2DG and DGA compounds]

Project description:To investigate the in vivo metabolic changes during WNV infection in a mouse model, we infected mice with WNV NY99 to compare to uninfected (mock) mice. We also use two compounds targeting energetic metabolism to analyze their effects on WNV infection We then performed gene expression profiling analysis using data obtained from RNA-seq from infected vs uninfected mice and treated mice.

2023-09-27 | GSE233215 | GEO

scRNA-seq of peripheral blood from West Nile Virus-infected patients

Project description:We profile the peripheral blood of patients infected with West Nile Virus with divergent disease-trajectories (West Nile Encephalitis, West Nile Fever, and asymptomatic) during relatively acute infection and at a convalescent timepoint (~90-days later) using single-cell RNA sequencing in an effort to uncover determinants of disease progression and flesh out the landscape of infection. In the blood of the infected patients, stratified cell-states involved in acute viral infection resolve into more homogenous states at the follow-up blood draws, A dramatic shared transcriptional shift between the primary blood-draws during acute infection and the 90-day follow-ups in all observed compartments allows us to highlight multiple cell-type and cell-state-specific patterns of gene expression.

2021-12-24 | GSE142595 | GEO

West Nile virus

Project description:West Nile virus overview

| PRJNA69671 | ENA

West Nile virus

Project description:West Nile virus: Genome sequencing

| PRJEB80643 | ENA